共 50 条
- [33] Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials [J]. EUROINTERVENTION, 2011, 7 (01) : 74 - 83
- [34] Comparison of Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients with Two Treated Vessels: 2-Year Results From the SPIRIT III Randomized Trial [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 150D - 150D
- [36] Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18): : 1663 - 1674